StockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL)

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Trading Down 2.1 %

Shares of BIOLASE stock opened at $0.01 on Friday. BIOLASE has a 1 year low of $0.02 and a 1 year high of $1.94. The stock has a 50-day moving average price of $0.01 and a 200 day moving average price of $0.01. The company has a market cap of $457,675.90, a P/E ratio of 0.00 and a beta of 0.67.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.